MyFinsight
Home
About
Contact
rcktw: the income statement
Download
Download image
Net loss
-$50,332,000
Accretion of discount on
investments, net
$1,679,000
Interest and other
income, net
$709,000
Interest expense
$473,000
Loss from operations
-$52,247,000
Total operating
expenses
$52,247,000
Restructuring
-$172,000
General and
administrative
$18,351,000
Research and development
$34,068,000
Back
Back
Income Statement
source: myfinsight.com
ROCKET PHARMACEUTICALS, INC. (RCKTW)
ROCKET PHARMACEUTICALS, INC. (RCKTW)